background
dengu
major
mosquitoborn
diseas
current
effect
antivir
vaccin
avail
effort
find
antivir
focus
bioflavonoid
plantderiv
polyphenol
compound
mani
potenti
health
benefit
present
studi
antivir
activ
four
type
bioflavonoid
dengu
viru
type
vero
cell
evalu
antidengu
activ
compound
determin
differ
stage
infect
replic
cycl
denv
replic
measur
foci
form
unit
reduct
assay
ffura
quantit
rtpcr
select
index
valu
si
determin
ratio
cytotox
concentr
cc
inhibitori
concentr
ic
compound
result
half
maxim
inhibitori
concentr
ic
quercetin
dengu
viru
ml
use
viru
adsorpt
cell
ic
decreas
ml
cell
treat
continu
h
viru
infect
day
postinfect
si
valu
quercetin
ml
respect
highest
compar
bioflavonoid
studi
naringin
exhibit
antiadsorpt
effect
ic
ml
relat
si
daidzein
show
weak
antidengu
activ
ic
ml
infect
cell
treat
viru
adsorpt
si
valu
compound
hesperetin
exhibit
antivir
activ
find
obtain
foci
form
unit
reduct
assay
ffura
corrobor
find
qrtpcr
assay
quercetin
daidzein
ml
reduc
rna
level
respect
signific
inhibit
rna
level
naringin
hesperetin
conclus
result
studi
suggest
quercetin
demonstr
signific
inhibitori
activ
bioflavonoid
includ
daidzein
naringin
hesperetin
show
minim
signific
inhibit
viru
replic
find
togeth
previous
report
suggest
select
group
bioflavonoid
includ
quercetin
fisetin
exhibit
signific
inhibitori
activ
dengu
viru
group
flavonoid
flavonol
could
investig
discov
common
mechan
inhibit
dengu
viru
replic
dengu
viru
denv
member
genu
flaviviru
flavivirida
famili
signific
human
pathogen
caus
wide
spectrum
clinic
ill
rang
silent
mild
febril
infect
selflimit
dengu
fever
df
sever
dengu
hemorrhag
fever
dhf
dengu
shock
syndrom
dss
four
dengu
viru
genotyp
transmit
human
mainli
two
speci
mosquito
aed
agypti
aed
albopictu
four
denv
caus
dengu
date
effect
vaccin
antivir
treatment
dengu
dengu
patient
usual
supportivelytr
recov
without
specif
treatment
measur
sever
studi
shown
level
viremia
correl
sever
diseas
high
viremia
often
seen
sever
dengu
henc
antivir
reduc
level
viremia
virem
phase
could
possibl
reduc
sever
dengu
plant
plant
deriv
compound
remain
import
sourc
discoveri
develop
new
antivir
drug
expect
low
side
effect
high
access
natur
numer
report
antivir
activ
variou
phytochem
dengu
virus
includ
variou
flavonoid
flavonoid
basic
low
molecular
weight
phenol
compound
found
wide
differ
kind
plant
differ
type
flavonoid
found
fruit
root
nut
seed
bark
steam
flower
plant
includ
quercetin
found
food
fruit
green
black
tea
appl
onion
citru
tomato
plant
antivir
activ
variou
flavonoid
also
report
virus
includ
human
cytomegaloviru
hcmv
type
human
adenovirus
present
studi
interest
examin
antidengu
viru
properti
quercetin
hesperetin
naringin
daidzein
hesperetin
flavonon
glycosid
form
hesperidin
water
solubl
could
found
variou
citru
fruit
ingest
hesperidin
sugar
moieti
releas
backbon
compound
aglycon
form
known
hesperetin
releas
vitro
antivir
activ
hesperetin
report
rna
virus
naringin
hand
flavonon
glycosid
found
abundantli
grapefruit
juic
antivir
activ
naringin
report
find
remain
controversi
daidzein
isoflavon
found
soybean
antivir
activ
influenza
virus
report
current
publish
data
possibl
antidengu
viru
activ
quercetin
hesperetin
naringin
daidzein
therefor
studi
evalu
compound
activ
ngc
strain
replic
cell
cultur
system
effect
compound
evalu
differ
stage
dengu
viru
replic
includ
viru
adsorpt
intracellular
replic
direct
virucid
activ
four
differ
type
bioflavonoid
quercetin
naringin
hesperetin
sigmaaldrich
st
loui
mo
usa
daidzein
indofin
chemic
co
inc
hillsborough
nj
usa
evalu
potenti
activ
dengu
viru
replic
dimethyl
sulfoxid
dmso
sigmaaldrich
st
loui
mo
usa
use
dissolv
lyophil
form
compound
prepar
stock
solut
mg
ml
store
c
stock
solut
dilut
use
cell
cultur
medium
steril
syring
filter
pore
size
millipor
usa
right
experi
mosquito
cell
line
deriv
aed
albopictu
vero
african
green
monkey
kidney
cell
line
use
studi
cell
line
maintain
propag
eagl
minimum
essenti
medium
emem
gibco
ny
usa
contain
fetal
bovin
serum
gibco
ny
usa
cultur
vero
cell
incub
c
c
respect
co
humidifi
chamber
time
viru
propag
serum
concentr
reduc
dengu
viru
new
guinea
c
strain
ngc
propag
use
cell
line
harvest
cpe
present
day
seven
postinfect
titrat
viral
stock
store
c
cell
line
viru
provid
virolog
laboratori
tropic
infecti
diseas
research
educ
center
faculti
medicin
univers
malaya
kuala
lumpur
malaysia
mtt
assay
perform
follow
manufactur
instruct
promega
wi
usa
briefli
confluent
vero
cell
cell
cultur
micropl
treat
differ
concentr
compound
triplic
treat
cell
incub
four
day
c
follow
addit
mtt
solut
well
micropl
incub
c
h
solubilisationstop
solut
ad
well
optic
densiti
od
well
measur
use
plate
reader
tecan
mannendorf
switzerland
doserespons
curv
plot
use
graph
pad
prism
graph
pad
softwar
inc
san
diego
ca
order
determin
prophylact
antidengu
activ
compound
differ
concentr
compound
ad
vero
monolay
cell
triplic
differ
time
h
viru
infect
h
preinfect
treatment
cell
wash
twice
steril
pb
ffu
inocul
cell
incub
c
h
determin
effect
continu
treatment
differ
concentr
compound
ad
vero
cell
h
preinfect
continu
day
postinfect
separ
experi
antivir
activ
compound
intracellular
replic
perform
inocul
ffu
viru
well
triplic
adsorpt
viru
cell
h
c
cell
wash
pb
elimin
unabsorb
virus
differ
concentr
compound
ad
cell
follow
day
incub
c
denv
rna
quantifi
use
quantit
rtpcr
anoth
experi
vero
cell
confluenc
infect
ffu
presenc
absenc
differ
concentr
compound
micropl
kept
c
h
viru
adsorpt
cell
wash
two
time
steril
pb
incub
c
four
day
direct
virucid
effect
bioflavonoid
investig
incub
suspens
contain
ffu
equal
volum
differ
concentr
compound
h
c
vero
cell
infect
treat
viral
suspens
triplic
h
adsorpt
c
cell
wash
twice
pb
order
remov
unabsorb
virus
micropl
incub
c
day
antivir
activ
test
compound
evalu
measur
reduct
number
viral
foci
briefli
confluent
monolay
vero
cell
prepar
well
cell
cultur
micropl
infect
cell
treat
use
differ
procedur
describ
overlaid
carboxi
methyl
cellulos
cmc
sigmaaldrich
st
loui
mo
usa
contain
emem
viral
foci
visual
use
peroxidasebas
foci
stain
assay
four
day
post
infect
number
foci
count
use
stereomicroscop
titer
viru
express
fociformingunit
ffu
percentag
viral
foci
reduct
rf
compar
control
calcul
follow
rf
ct
c
mean
number
foci
neg
control
well
without
compound
mean
number
foci
treat
well
reduct
number
viral
foci
verifi
use
quantit
rtpcr
qrtpcr
quantit
rtpcr
perform
determin
effect
bioflavonoid
denv
replic
quantifi
genom
rna
copi
base
method
describ
previous
modif
briefli
intracellular
extracellular
rna
harvest
denvinfect
vero
cell
viral
rna
extract
use
two
type
rna
extract
kit
qiaamp
viral
rna
mini
kit
rneasi
mini
kit
qiagen
hilden
germani
quantit
rtpcr
assay
perform
ad
extract
denv
rna
sensimix
sybr
green
reagent
quantac
watford
unit
kingdom
contain
sensimix
onestep
sybr
green
solut
unit
rnase
inhibitor
pmol
forward
dnf
also
revers
primer
sampl
assay
triplic
amplif
perform
use
dna
engin
opticon
system
mj
researchbiorad
hercul
ca
follow
thermal
condit
revers
transcript
min
initi
denatur
min
follow
cycl
sec
sec
sec
melt
curv
analysi
subsequ
perform
temperatur
verifi
assay
specif
absolut
quantit
viral
rna
standard
curv
establish
serial
dilut
rna
extract
stock
known
titer
graph
pad
prism
window
version
graph
pad
softwar
inc
san
diego
ca
use
determin
cytotox
concentr
cc
inhibitori
concentr
ic
valu
bioflavonoid
select
index
valu
si
determin
ratio
cc
ic
compound
mtt
assay
use
determin
cytotox
bioflavonoid
vero
cell
cc
valu
compound
calcul
tabl
figur
vero
cell
treat
bioflavonoid
day
durat
use
antivir
activ
assay
result
show
hesperetin
cc
ml
cytotox
compound
vero
cell
compar
test
compound
quercetin
daidzein
show
lower
toxic
vero
cell
cc
ml
respect
meanwhil
naringin
cc
ml
show
least
cytotox
effect
vero
cell
cell
treat
vehicl
control
dmso
show
cytotox
vero
cell
result
vero
cell
pretreat
compound
show
ml
quercetin
could
decreas
number
foci
compar
nontreat
cell
howev
prophylact
activ
compound
data
shown
postadsorpt
assay
quercetin
exhibit
signific
antivir
activ
amongst
bioflavonoid
test
ic
ml
figur
si
valu
quercetin
postadsorpt
assay
rel
high
also
demonstr
level
specif
rna
product
presenc
ml
quercetin
decreas
compar
nontreat
infect
cell
figur
daidzein
show
weak
antidengu
activ
ic
ml
infect
cell
treat
adsorpt
figur
relat
si
valu
level
rna
product
presenc
ml
daidzein
decreas
compar
nontreat
infect
cell
figur
naringin
hesperetin
exhibit
antidengu
activ
use
adsorpt
vero
cell
figur
although
signific
direct
virucid
activ
quercetin
continu
treatment
cell
h
viru
infect
day
postinfect
exhibit
antidengu
activ
ic
ml
figur
si
valu
continu
treatment
quercetin
higher
si
valu
postadsorpt
assay
addit
level
rna
product
decreas
vero
cell
treat
ml
quercetin
h
viru
infect
day
post
infect
figur
signific
chang
antivir
activ
daidzein
cell
treat
continu
h
viru
infect
day
post
infect
compar
antidengu
activ
postadsorpt
treatment
figur
signific
antivir
activ
naringin
hesperetin
observ
continu
treatment
figur
howev
naringin
exhibit
antiadsorpt
activ
ad
cell
time
viru
adsorpt
ic
valu
naringin
ml
relat
si
figur
reduct
rna
product
presenc
ml
naringin
figur
major
viral
foci
cell
treat
quercetin
appear
smaller
less
intens
stain
diffus
within
focu
figur
compar
larger
welldefin
intens
stain
foci
untreat
cell
figur
observ
consist
reduct
percentag
foci
rna
copi
number
result
direct
virucid
activ
evalu
compound
show
extracellular
inhibitori
activ
test
figur
antiadsorpt
activ
flavonoid
flavonoid
ad
directli
viru
inocula
h
c
inocula
use
infect
vero
cell
monolay
well
cell
cultur
micropl
reduct
foci
form
unit
calcul
rel
control
maintain
parallel
respect
rna
copi
number
quantifi
use
qrtpcr
b
data
triplic
experi
plot
use
graph
pad
prism
version
graph
pad
softwar
inc
san
diego
ca
reduct
intracellular
replic
dengu
viru
follow
treatment
glabranin
glabranin
respect
similarli
synthet
flavonoid
deriv
also
show
antivir
activ
cell
wherea
pinostrobin
report
inhibit
proteas
enzym
import
dengu
viru
replic
vitro
studi
suggest
flavonoid
group
could
consist
select
compound
possess
inhibitori
activ
denv
investig
mani
flavonoid
could
affect
denv
infect
present
studi
examin
potenti
effect
quercetin
naringin
hesperetin
daidzein
dengu
viru
infect
vero
cell
unlik
previou
studi
evalu
antivir
activ
flavonoid
adsorpt
viru
cell
present
studi
evalu
antivir
activ
differ
treatment
procedur
tailor
determin
prophylact
post
adsorpt
continu
treatment
direct
virucid
activ
quercetin
naringin
daidzein
hesperetin
find
demonstr
quercetin
compound
among
test
flavonoid
consist
show
signific
antivir
activ
vero
cell
select
indic
quercetin
infect
cell
treat
uninfect
cell
treat
continu
h
infect
day
postinfect
respect
note
differ
si
valu
quercetin
could
due
intracellular
accumul
quercetin
continu
treatment
weak
effect
prophylact
activ
quercetin
howev
also
observ
find
suggest
main
antidengu
activ
quercetin
like
due
activ
differ
stage
intracellular
replic
instead
earli
stage
replic
cycl
viru
attach
entri
although
direct
virucid
activ
antiattach
activ
quercetin
observ
present
studi
antivir
activ
quercetin
human
cytomegaloviru
report
ic
quercetin
also
report
effect
herp
virus
specif
si
compar
si
mechan
quercetin
exert
antivir
effect
known
howev
effect
flavonoid
cellular
rna
polymeras
format
complex
rna
report
suggest
quercetin
could
also
affect
similar
replic
enzym
sylimarin
flavonoid
found
effect
hepat
c
viru
hcv
anoth
member
flavivirida
famili
inhibit
viru
replic
inhibit
activ
viral
rna
polymeras
studi
result
qrtpcr
support
find
viral
foci
reduct
assay
quercetin
inhibit
replic
signific
reduct
denv
specif
rna
suggest
quercetin
may
also
target
viru
replic
machineri
name
inhibit
rna
polymeras
antivir
activ
naringin
evalu
herpesvirus
rotaviru
report
antivir
activ
inconclus
addit
report
naringin
exhibit
antivir
activ
anoth
rna
viru
sindbi
viru
present
studi
antidengu
activ
flavonoid
demonstr
adsorpt
attach
viru
vero
cell
base
antivir
activ
ic
ml
relat
select
index
si
may
good
candid
develop
antidengu
drug
similarli
daidzein
activ
signific
compar
quercetin
si
continu
treatment
infect
vero
cell
h
viru
infect
day
post
infect
improv
antidengu
activ
significantli
compound
therefor
could
suitabl
candid
develop
antidengu
drug
hesperetin
flavonoid
evalu
studi
show
antidengu
activ
stage
viru
infect
replic
process
despit
previous
report
antivir
activ
hesperetin
sindbi
viru
therefor
hesperetin
also
recommend
investig
antidengu
drug
develop
experi
show
dmso
highest
concentr
solvent
use
bioflavonoid
treatment
exhibit
antivir
activ
elimin
probabl
antivir
activ
dmso
find
studi
suggest
select
flavonoid
includ
quercetin
fisetin
flavonol
exhibit
signific
denv
replic
inhibit
properti
flavonoid
gener
share
common
basic
molecular
base
structur
flavon
show
flavanon
hesperetin
flavanon
glycosid
naringin
show
signific
antidenv
replic
activ
addit
earlier
shown
naringenin
anoth
flavanon
metabol
naringin
daidzein
isoflavon
also
signific
denv
replic
inhibit
properti
quercetin
shown
effect
inhibit
denv
replic
glycosid
form
rutin
show
signific
inhibit
properti
suggest
flavonol
could
basic
molecul
possess
anti
denv
replic
properti
specif
structur
properti
differ
flavonol
deriv
would
differ
effect
efficaci
compound
dengu
demonstr
vitro
flavonol
includ
quercetin
fisetin
possess
anti
denv
replic
properti
necessarili
translat
immedi
use
compound
antivir
denv
studi
need
demonstr
antivir
activ
compound
differ
genotyp
dengu
viru
appropri
anim
model
also
need
address
issu
low
bioavail
quercetin
especi
therapeut
use
sever
strategi
increas
bioavail
quercetin
includ
use
lipid
emulsifi
cocryst
quercetin
use
esterbas
precursor
investig
topic
research
would
combin
drug
studi
current
calcul
ic
valu
antivir
efficaci
quercetin
improv
possibl
combin
potenti
antidengu
compound
exemplifi
studi
report
synergist
effect
combin
standard
antivir
drug
ribavirin
effect
dengu
infect
conclus
present
studi
demonstr
bioflavonoid
quercetin
exhibit
signific
anti
denv
replic
properti
show
quercetin
affect
intracellular
denv
viru
replic
denv
attach
entri
process
result
togeth
earlier
find
report
anti
denv
properti
fisetin
suggest
flavonol
could
investig
specif
use
candid
antidenv
therapeut
